Everything you need to know about TMS for Social Anxiety Disorder: What the Research Says — how it works, what it costs, and how to find a provider who actually knows what they're doing.

Social anxiety disorder (SAD) affects approximately 15 million American adults, making it one of the most prevalent anxiety disorders in the United States. Characterized by an intense, persistent fear of being watched and judged by others, SAD can significantly impair work performance, relationships, and daily functioning. While cognitive-behavioral therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs) remain first-line treatments, a substantial proportion of patients experience only partial relief. Transcranial magnetic stimulation (TMS) is emerging as a novel intervention that targets the neural circuits underlying social anxiety, offering hope to those who have not responded adequately to traditional approaches.

What You’ll Learn

• How social anxiety disorder affects the amygdala and prefrontal cortex
• The difference between right-sided inhibitory and left-sided excitatory TMS for social anxiety
• What clinical trials show about TMS response rates for SAD
• Why TMS is not yet FDA-cleared specifically for social anxiety
• What to expect from off-label TMS treatment for social anxiety

Understanding the Neuroscience of Social Anxiety

Research using functional neuroimaging has consistently identified hyperactivity in the amygdala — the brain’s threat-detection center — as a hallmark of social anxiety disorder. When socially anxious individuals anticipate or experience social evaluation, their amygdalae show exaggerated responses compared to non-anxious controls. This hyperactivation is accompanied by altered connectivity between the amygdala and the prefrontal cortex, the region responsible for regulating emotional responses and putting fear into context.

The ventromedial prefrontal cortex (vmPFC) and the dorsolateral prefrontal cortex (dlPFC) both play critical roles in fear extinction and anxiety regulation. In social anxiety, these top-down regulatory mechanisms are often underactive, meaning the prefrontal cortex fails to adequately suppress amygdala hyperreactivity. This creates a state where threat signals from the amygdala go unchecked, perpetuating the cycle of anxiety.

How TMS Targets Social Anxiety

TMS for social anxiety typically targets the dlPFC, either on the right side, the left side, or bilaterally, depending on the treatment protocol. The goal is to modulate the dysfunctional connectivity between the prefrontal cortex and the amygdala.

Right-sided low-frequency (inhibitory) TMS to the dlPFC aims to reduce the hyperactive threat-detection circuitry. By applying slow, inhibitory pulses to the right dlPFC, clinicians seek to dampen the amygdala’s exaggerated responses to social threat cues.

Left-sided high-frequency (excitatory) TMS to the dlPFC, by contrast, aims to enhance the prefrontal cortex’s regulatory capacity. By increasing activity in this region, the treatment hopes to restore top-down control over the amygdala, allowing patients to reappraise social situations with less fear.

Some protocols use bilateral stimulation, targeting both hemispheres sequentially to address the disorder from multiple angles simultaneously.

What the Research Shows

Several clinical trials have investigated TMS as a treatment for social anxiety disorder, with generally encouraging results.

A landmark randomized controlled trial published in the Journal of Affective Disorders found that participants receiving active high-frequency TMS to the left dlPFC showed significantly greater reductions in social anxiety symptoms compared to those receiving sham (placebo) stimulation. Improvements were measured using both the Liebowitz Social Anxiety Scale (LSAS) and the Social Phobia Inventory (SPIN), two validated clinical instruments. The treatment effect was apparent after approximately four weeks of daily sessions.

Neuroimaging studies have corroborated these clinical findings, showing that successful TMS treatment is associated with reduced amygdala reactivity to social threat stimuli. In other words, TMS appears to normalize the very brain activity patterns that drive social anxiety — not just reduce symptoms on paper, but actually change the underlying neural dysfunction.

A 2022 meta-analysis reviewing multiple TMS protocols for anxiety disorders (including social anxiety) concluded that TMS produces moderate to large effect sizes, with response rates ranging from 35% to 55% depending on the protocol and patient population. While these numbers are promising, researchers emphasize that larger, multi-site trials are still needed to establish definitive treatment guidelines.

FDA Status and Clinical Availability

As of early 2026, TMS is not FDA-cleared specifically for social anxiety disorder. The FDA has cleared TMS for major depressive disorder, obsessive-compulsive disorder, and smoking cessation. However, physicians may prescribe TMS off-label for social anxiety, and many psychiatric practices already do so for treatment-resistant cases.

Off-label use means that insurance coverage varies significantly by plan. Some insurers will cover TMS for social anxiety if there is a comorbid diagnosis of depression, while others require the patient to pay out of pocket. Patients should check with their provider and insurance plan before beginning treatment.

What to Expect From Treatment

For social anxiety, TMS protocols typically involve daily sessions five days per week for four to six weeks, with each session lasting approximately 20 to 40 minutes. Patients remain awake and alert throughout. There is no anesthesia, no hospitalization, and no recovery time — most people return to their normal activities immediately after each session.

Common side effects are mild and include scalp discomfort at the stimulation site, headache, and occasional facial twitching during the session. These side effects typically diminish over the first week of treatment.

Is TMS Right for Your Social Anxiety?

TMS for social anxiety is most appropriate for individuals who have not achieved adequate relief from first-line treatments such as CBT or SSRIs. It is non-invasive, well-tolerated by most patients, and supported by a growing body of evidence.

If you are considering TMS for social anxiety disorder, consult with a board-certified psychiatrist who has experience with neuromodulation. A thorough evaluation will determine whether TMS is appropriate for your specific presentation, and whether a right-sided, left-sided, or bilateral protocol is most likely to benefit you.

The field of neuromodulation for anxiety disorders is evolving rapidly. As research continues to clarify which protocols work best for which patients, TMS is positioned to become an increasingly important tool in the psychiatrist’s arsenal against social anxiety.